The overall value of the Russian pharmaceutical market in 2009 amounted to U.S.$18.36 billion in terms of retail prices, 18 per cent higher compared to the previous year.........The Russian market will grow by more than 11 per cent in 2010 in ruble terms and by 16 per cent in U.S. dollars to reach a value of U.S.$20 billion. More significant growth is expected in 2011 - DSM Group, Moscow, 11th March 2010.

Biopharm Analytica offers a range of bespoke consulting and research services with regard to the bioscience and pharmaceutical sectors in Russia and the Newly Independent States. The UK-based company has undertaken market surveys for leading biotechnology multinationals and completed studies of niche technologies and markets. To discuss your detailed requirements with one of our analysts please call +44 (0)121 2702854 .

Biopharm Analytica also provides access to an independent English language online business news and information service focusing on developments in biotechnology and the pharmaceutical industry in Russia and the Newly Independent States (NIS). Drawing upon lead-edge academic research in the United Kingdom, Biopharm Analytica provides unique real-time, in-depth news coverage and analysis of the biopharmaceutical industry in the Russian Federation and the NIS. One of its key focuses is on opportunities for international companies with a strong emphasis on high-value projects which may provide opportunities for global biotech companies. Coverage is also provided of pharmaceutical and biotech R & D and manufacturing projects within Russia and the NIS. Subscription to Biopharm Analytica by registered users, will allow immediate and privileged access to the information service covering major news stories impacting upon the biotechnology and pharmaceutical sectors in Russia and the NIS. A major searchable on-line database of news reports, providing an invaluable source of business intelligence with regard to the Russian biopharmaceutical sector, is available only to subscribers. It is anticipated that Biopharm Analytica's blend of news, analysis and comment will rapidly become an indispensable adjunct to those companies and analysts seeking new insight into the Russian and NIS biotechnology and pharmaceutical sectors. Credit card payments are accepted using electronic card processing facilities provided by HSBC. To discuss your subscription requirements with one of our sales staff please call +44 (0)121 2702854 .

© Biopharm Analytica Limited 2010. All Rights Reserved. This site is owned and operated by Biopharm Analytica Limited. Registered Office: Suite B, 29 Harley Street, London, W1G 9QR. Registered in England and Wales. Reg. No. 5360763. VAT Reg. No. 930 3219 57.